The sum of
glyco- and tauro-conjugates was calculated by adding the concentrations of conjugated CDCA, CA, DCA, and LCA.
Assuming this phenomenon to be important in FQ-treated patients, the
glyco- and lipolysis inhibitors could be considered as OS reductors.
The relationship of adiponectin level with
glyco- sylated hemoglobin and lipid profile in patients of type 2 diabetes has been investigated in different regions and racial groups.16-19 However; limited literature is available on serum adiponectin level and its relationship with the above clinical and biochemical parameters in the population of KPK.